| UniProt ID | DLDH_HUMAN | |
|---|---|---|
| UniProt AC | P09622 | |
| Protein Name | Dihydrolipoyl dehydrogenase, mitochondrial | |
| Gene Name | DLD | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 509 | |
| Subcellular Localization | Mitochondrion matrix . Nucleus . Cell projection, cilium, flagellum . Cytoplasmic vesicle, secretory vesicle, acrosome . Mainly localizes in the mitochondrion. A small fraction localizes to the nucleus, where the 2-oxoglutarate dehydrogenase complex | |
| Protein Description | Lipoamide dehydrogenase is a component of the glycine cleavage system as well as an E3 component of three alpha-ketoacid dehydrogenase complexes (pyruvate-, alpha-ketoglutarate-, and branched-chain amino acid-dehydrogenase complex). [PubMed: 15712224] | |
| Protein Sequence | MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Acetylation | HFNRISHGLQGLSAV CCCHHCCCCCCCCCC | 16.95 | - | |
| 28 | Ubiquitination | SHGLQGLSAVPLRTY CCCCCCCCCCCCCCC | 33.76 | - | |
| 33 | Ubiquitination | GLSAVPLRTYADQPI CCCCCCCCCCCCCCC | 21.44 | - | |
| 34 | Phosphorylation | LSAVPLRTYADQPID CCCCCCCCCCCCCCC | 30.64 | 21406692 | |
| 35 | Phosphorylation | SAVPLRTYADQPIDA CCCCCCCCCCCCCCC | 11.18 | 21406692 | |
| 44 | Acetylation | DQPIDADVTVIGSGP CCCCCCCEEEECCCC | 5.02 | - | |
| 44 | Ubiquitination | DQPIDADVTVIGSGP CCCCCCCEEEECCCC | 5.02 | - | |
| 44 | Acetylation | DQPIDADVTVIGSGP CCCCCCCEEEECCCC | 5.02 | 19608861 | |
| 44 | Ubiquitination | DQPIDADVTVIGSGP CCCCCCCEEEECCCC | 5.02 | 19608861 | |
| 45 | Phosphorylation | QPIDADVTVIGSGPG CCCCCCEEEECCCCC | 13.62 | 21406692 | |
| 49 | Phosphorylation | ADVTVIGSGPGGYVA CCEEEECCCCCHHHH | 30.59 | 21406692 | |
| 54 | Phosphorylation | IGSGPGGYVAAIKAA ECCCCCHHHHHHHHH | 7.88 | 21406692 | |
| 59 | Ubiquitination | GGYVAAIKAAQLGFK CHHHHHHHHHHCCCE | 32.70 | - | |
| 59 | Ubiquitination | GGYVAAIKAAQLGFK CHHHHHHHHHHCCCE | 32.70 | - | |
| 60 | Ubiquitination | GYVAAIKAAQLGFKT HHHHHHHHHHCCCEE | 8.37 | - | |
| 66 | Acetylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | - | |
| 66 | 2-Hydroxyisobutyrylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | - | |
| 66 | Acetylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | 25825284 | |
| 66 | Malonylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | 26320211 | |
| 66 | Methylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | - | |
| 66 | Succinylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | - | |
| 66 | Succinylation | KAAQLGFKTVCIEKN HHHHCCCEEEEEECC | 37.95 | 27452117 | |
| 67 | Acetylation | AAQLGFKTVCIEKNE HHHCCCEEEEEECCC | 20.53 | - | |
| 67 | Ubiquitination | AAQLGFKTVCIEKNE HHHCCCEEEEEECCC | 20.53 | - | |
| 67 | Phosphorylation | AAQLGFKTVCIEKNE HHHCCCEEEEEECCC | 20.53 | 30576142 | |
| 72 | Acetylation | FKTVCIEKNETLGGT CEEEEEECCCCCCCE | 39.92 | 25953088 | |
| 81 | Ubiquitination | ETLGGTCLNVGCIPS CCCCCEEEECCEECC | 6.13 | 21890473 | |
| 88 | Phosphorylation | LNVGCIPSKALLNNS EECCEECCHHHHCCC | 15.62 | 24719451 | |
| 104 | Ubiquitination | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | 21890473 | |
| 104 | Acetylation | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | - | |
| 104 | Ubiquitination | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | 21890473 | |
| 104 | 2-Hydroxyisobutyrylation | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | - | |
| 104 | Acetylation | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | 23954790 | |
| 104 | Malonylation | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | 26320211 | |
| 104 | Succinylation | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | - | |
| 104 | Succinylation | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | - | |
| 104 | Ubiquitination | YYHMAHGKDFASRGI CHHHHCCCCHHHCCC | 39.54 | 21890473 | |
| 109 | Ubiquitination | HGKDFASRGIEMSEV CCCCHHHCCCCHHHH | 46.83 | 21890473 | |
| 109 | Methylation | HGKDFASRGIEMSEV CCCCHHHCCCCHHHH | 46.83 | - | |
| 120 | Ubiquitination | MSEVRLNLDKMMEQK HHHHHHCHHHHHHHH | 8.73 | 21890473 | |
| 122 | 2-Hydroxyisobutyrylation | EVRLNLDKMMEQKST HHHHCHHHHHHHHHH | 43.23 | - | |
| 122 | Acetylation | EVRLNLDKMMEQKST HHHHCHHHHHHHHHH | 43.23 | 23954790 | |
| 122 | Succinylation | EVRLNLDKMMEQKST HHHHCHHHHHHHHHH | 43.23 | - | |
| 122 | Succinylation | EVRLNLDKMMEQKST HHHHCHHHHHHHHHH | 43.23 | 27452117 | |
| 127 | 2-Hydroxyisobutyrylation | LDKMMEQKSTAVKAL HHHHHHHHHHHHHHH | 36.15 | - | |
| 127 | Acetylation | LDKMMEQKSTAVKAL HHHHHHHHHHHHHHH | 36.15 | 26210075 | |
| 127 | Ubiquitination | LDKMMEQKSTAVKAL HHHHHHHHHHHHHHH | 36.15 | - | |
| 132 | Ubiquitination | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | 21890473 | |
| 132 | Ubiquitination | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | 21890473 | |
| 132 | 2-Hydroxyisobutyrylation | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | - | |
| 132 | Acetylation | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | 25038526 | |
| 132 | Succinylation | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | - | |
| 132 | Succinylation | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | 21890473 | |
| 132 | Ubiquitination | EQKSTAVKALTGGIA HHHHHHHHHHHHHHH | 34.90 | 21890473 | |
| 135 | Phosphorylation | STAVKALTGGIAHLF HHHHHHHHHHHHHHH | 37.92 | - | |
| 143 | Ubiquitination | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | 21890473 | |
| 143 | 2-Hydroxyisobutyrylation | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | - | |
| 143 | Acetylation | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | 19608861 | |
| 143 | Malonylation | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | 26320211 | |
| 143 | Methylation | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | 19608861 | |
| 143 | Succinylation | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | - | |
| 143 | Succinylation | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | - | |
| 143 | Ubiquitination | GGIAHLFKQNKVVHV HHHHHHHHCCCEEEE | 60.36 | 21890473 | |
| 146 | Acetylation | AHLFKQNKVVHVNGY HHHHHCCCEEEECCC | 43.04 | 25038526 | |
| 153 | Phosphorylation | KVVHVNGYGKITGKN CEEEECCCCEECCCC | 15.28 | 28152594 | |
| 155 | Acetylation | VHVNGYGKITGKNQV EEECCCCEECCCCCE | 28.72 | 30582533 | |
| 159 | Acetylation | GYGKITGKNQVTATK CCCEECCCCCEEEEE | 35.24 | 25953088 | |
| 159 | Succinylation | GYGKITGKNQVTATK CCCEECCCCCEEEEE | 35.24 | - | |
| 159 | Succinylation | GYGKITGKNQVTATK CCCEECCCCCEEEEE | 35.24 | 27452117 | |
| 159 | Ubiquitination | GYGKITGKNQVTATK CCCEECCCCCEEEEE | 35.24 | - | |
| 166 | 2-Hydroxyisobutyrylation | KNQVTATKADGGTQV CCCEEEEECCCCCEE | 41.85 | - | |
| 166 | Acetylation | KNQVTATKADGGTQV CCCEEEEECCCCCEE | 41.85 | 23236377 | |
| 166 | Malonylation | KNQVTATKADGGTQV CCCEEEEECCCCCEE | 41.85 | 26320211 | |
| 166 | Succinylation | KNQVTATKADGGTQV CCCEEEEECCCCCEE | 41.85 | - | |
| 166 | Succinylation | KNQVTATKADGGTQV CCCEEEEECCCCCEE | 41.85 | - | |
| 166 | Ubiquitination | KNQVTATKADGGTQV CCCEEEEECCCCCEE | 41.85 | 21906983 | |
| 168 | Acetylation | QVTATKADGGTQVID CEEEEECCCCCEEEE | 58.57 | - | |
| 168 | Acetylation | QVTATKADGGTQVID CEEEEECCCCCEEEE | 58.57 | 19608861 | |
| 208 | Phosphorylation | VSSTGALSLKKVPEK EECCCCCCCCCCCCC | 37.29 | 24719451 | |
| 219 | Acetylation | VPEKMVVIGAGVIGV CCCCEEEEECCEEEE | 1.81 | 19608861 | |
| 221 | Acetylation | EKMVVIGAGVIGVEL CCEEEEECCEEEEHH | 9.65 | - | |
| 221 | Ubiquitination | EKMVVIGAGVIGVEL CCEEEEECCEEEEHH | 9.65 | - | |
| 221 | Acetylation | EKMVVIGAGVIGVEL CCEEEEECCEEEEHH | 9.65 | 19608861 | |
| 221 | Ubiquitination | EKMVVIGAGVIGVEL CCEEEEECCEEEEHH | 9.65 | 19608861 | |
| 230 | Phosphorylation | VIGVELGSVWQRLGA EEEEHHHHHHHHHCC | 32.57 | - | |
| 247 | Acetylation | TAVEFLGHVGGVGID EEEHHHCCCCCCCCC | 19.73 | - | |
| 247 | Ubiquitination | TAVEFLGHVGGVGID EEEHHHCCCCCCCCC | 19.73 | - | |
| 267 | 2-Hydroxyisobutyrylation | NFQRILQKQGFKFKL HHHHHHHHCCCEEEE | 49.28 | - | |
| 267 | Acetylation | NFQRILQKQGFKFKL HHHHHHHHCCCEEEE | 49.28 | 23954790 | |
| 267 | Malonylation | NFQRILQKQGFKFKL HHHHHHHHCCCEEEE | 49.28 | 26320211 | |
| 267 | Succinylation | NFQRILQKQGFKFKL HHHHHHHHCCCEEEE | 49.28 | 27452117 | |
| 267 | Ubiquitination | NFQRILQKQGFKFKL HHHHHHHHCCCEEEE | 49.28 | 19608861 | |
| 271 | Acetylation | ILQKQGFKFKLNTKV HHHHCCCEEEEECEE | 48.70 | 25038526 | |
| 272 | Ubiquitination | LQKQGFKFKLNTKVT HHHCCCEEEEECEEE | 11.54 | 21890473 | |
| 272 | Acetylation | LQKQGFKFKLNTKVT HHHCCCEEEEECEEE | 11.54 | 19608861 | |
| 272 | Ubiquitination | LQKQGFKFKLNTKVT HHHCCCEEEEECEEE | 11.54 | 19608861 | |
| 273 | Acetylation | QKQGFKFKLNTKVTG HHCCCEEEEECEEEC | 41.22 | 2402229 | |
| 273 | Succinylation | QKQGFKFKLNTKVTG HHCCCEEEEECEEEC | 41.22 | - | |
| 273 | Succinylation | QKQGFKFKLNTKVTG HHCCCEEEEECEEEC | 41.22 | - | |
| 276 | Phosphorylation | GFKFKLNTKVTGATK CCEEEEECEEECCEE | 37.01 | 20068231 | |
| 277 | 2-Hydroxyisobutyrylation | FKFKLNTKVTGATKK CEEEEECEEECCEEC | 36.40 | - | |
| 277 | Acetylation | FKFKLNTKVTGATKK CEEEEECEEECCEEC | 36.40 | 25953088 | |
| 277 | Succinylation | FKFKLNTKVTGATKK CEEEEECEEECCEEC | 36.40 | - | |
| 277 | Succinylation | FKFKLNTKVTGATKK CEEEEECEEECCEEC | 36.40 | 27452117 | |
| 277 | Ubiquitination | FKFKLNTKVTGATKK CEEEEECEEECCEEC | 36.40 | - | |
| 279 | Phosphorylation | FKLNTKVTGATKKSD EEEECEEECCEECCC | 23.74 | 20068231 | |
| 282 | Phosphorylation | NTKVTGATKKSDGKI ECEEECCEECCCCCE | 40.11 | 20068231 | |
| 283 | 2-Hydroxyisobutyrylation | TKVTGATKKSDGKID CEEECCEECCCCCEE | 50.15 | - | |
| 285 | Phosphorylation | VTGATKKSDGKIDVS EECCEECCCCCEEEE | 53.83 | - | |
| 292 | Phosphorylation | SDGKIDVSIEAASGG CCCCEEEEEEECCCC | 15.80 | 27251275 | |
| 297 | Ubiquitination | DVSIEAASGGKAEVI EEEEEECCCCCEEEE | 55.94 | 21890473 | |
| 297 | Phosphorylation | DVSIEAASGGKAEVI EEEEEECCCCCEEEE | 55.94 | 25159151 | |
| 298 | Ubiquitination | VSIEAASGGKAEVIT EEEEECCCCCEEEEE | 36.57 | 21890473 | |
| 311 | Acetylation | ITCDVLLVCIGRRPF EEEEEEEEEECCCCC | 1.63 | - | |
| 311 | Ubiquitination | ITCDVLLVCIGRRPF EEEEEEEEEECCCCC | 1.63 | - | |
| 311 | Acetylation | ITCDVLLVCIGRRPF EEEEEEEEEECCCCC | 1.63 | 19608861 | |
| 311 | Ubiquitination | ITCDVLLVCIGRRPF EEEEEEEEEECCCCC | 1.63 | 19608861 | |
| 318 | Acetylation | VCIGRRPFTKNLGLE EEECCCCCCCCCCHH | 16.81 | - | |
| 318 | Ubiquitination | VCIGRRPFTKNLGLE EEECCCCCCCCCCHH | 16.81 | - | |
| 318 | Acetylation | VCIGRRPFTKNLGLE EEECCCCCCCCCCHH | 16.81 | 19608861 | |
| 320 | Ubiquitination | IGRRPFTKNLGLEEL ECCCCCCCCCCHHHH | 51.02 | 21890473 | |
| 320 | 2-Hydroxyisobutyrylation | IGRRPFTKNLGLEEL ECCCCCCCCCCHHHH | 51.02 | - | |
| 320 | Acetylation | IGRRPFTKNLGLEEL ECCCCCCCCCCHHHH | 51.02 | 23954790 | |
| 320 | Ubiquitination | IGRRPFTKNLGLEEL ECCCCCCCCCCHHHH | 51.02 | 21906983 | |
| 321 | Acetylation | GRRPFTKNLGLEELG CCCCCCCCCCHHHHC | 35.96 | - | |
| 321 | Ubiquitination | GRRPFTKNLGLEELG CCCCCCCCCCHHHHC | 35.96 | - | |
| 321 | Acetylation | GRRPFTKNLGLEELG CCCCCCCCCCHHHHC | 35.96 | 19608861 | |
| 323 | Ubiquitination | RPFTKNLGLEELGIE CCCCCCCCHHHHCCE | 40.20 | 21890473 | |
| 331 | Ubiquitination | LEELGIELDPRGRIP HHHHCCEECCCCCCC | 11.82 | - | |
| 341 | Ubiquitination | RGRIPVNTRFQTKIP CCCCCCCCCCCCCCC | 32.85 | - | |
| 341 | Phosphorylation | RGRIPVNTRFQTKIP CCCCCCCCCCCCCCC | 32.85 | 20068231 | |
| 346 | Ubiquitination | VNTRFQTKIPNIYAI CCCCCCCCCCCEEEE | 45.44 | 21890473 | |
| 346 | Ubiquitination | VNTRFQTKIPNIYAI CCCCCCCCCCCEEEE | 45.44 | - | |
| 346 | Acetylation | VNTRFQTKIPNIYAI CCCCCCCCCCCEEEE | 45.44 | 23236377 | |
| 346 | Succinylation | VNTRFQTKIPNIYAI CCCCCCCCCCCEEEE | 45.44 | 23954790 | |
| 346 | Ubiquitination | VNTRFQTKIPNIYAI CCCCCCCCCCCEEEE | 45.44 | 21890473 | |
| 362 | Acetylation | DVVAGPMLAHKAEDE CEECCCHHCCCCCCC | 5.20 | 19608861 | |
| 362 | Ubiquitination | DVVAGPMLAHKAEDE CEECCCHHCCCCCCC | 5.20 | 19608861 | |
| 369 | Acetylation | LAHKAEDEGIICVEG HCCCCCCCCEEEEEC | 43.74 | 19608861 | |
| 372 | Acetylation | KAEDEGIICVEGMAG CCCCCCEEEEECCCC | 2.94 | 19608861 | |
| 392 | Ubiquitination | DYNCVPSVIYTHPEV ECCCCCEEEECCCCE | 2.95 | 21890473 | |
| 406 | Ubiquitination | VAWVGKSEEQLKEEG EEECCCCHHHHHHCC | 53.93 | - | |
| 410 | Acetylation | GKSEEQLKEEGIEYK CCCHHHHHHCCCEEE | 54.11 | 19608861 | |
| 410 | Malonylation | GKSEEQLKEEGIEYK CCCHHHHHHCCCEEE | 54.11 | 26320211 | |
| 410 | Succinylation | GKSEEQLKEEGIEYK CCCHHHHHHCCCEEE | 54.11 | - | |
| 410 | Succinylation | GKSEEQLKEEGIEYK CCCHHHHHHCCCEEE | 54.11 | - | |
| 410 | Ubiquitination | GKSEEQLKEEGIEYK CCCHHHHHHCCCEEE | 54.11 | 19608861 | |
| 417 | Ubiquitination | KEEGIEYKVGKFPFA HHCCCEEEECCCCCC | 31.55 | 21890473 | |
| 417 | 2-Hydroxyisobutyrylation | KEEGIEYKVGKFPFA HHCCCEEEECCCCCC | 31.55 | - | |
| 417 | Acetylation | KEEGIEYKVGKFPFA HHCCCEEEECCCCCC | 31.55 | 19608861 | |
| 417 | Ubiquitination | KEEGIEYKVGKFPFA HHCCCEEEECCCCCC | 31.55 | 19608861 | |
| 420 | Acetylation | GIEYKVGKFPFAANS CCEEEECCCCCCCCC | 53.50 | 23954790 | |
| 420 | Malonylation | GIEYKVGKFPFAANS CCEEEECCCCCCCCC | 53.50 | 26320211 | |
| 420 | Ubiquitination | GIEYKVGKFPFAANS CCEEEECCCCCCCCC | 53.50 | 19608861 | |
| 430 | Acetylation | FAANSRAKTNADTDG CCCCCCCCCCCCCCC | 41.00 | 26210075 | |
| 430 | Succinylation | FAANSRAKTNADTDG CCCCCCCCCCCCCCC | 41.00 | - | |
| 430 | Succinylation | FAANSRAKTNADTDG CCCCCCCCCCCCCCC | 41.00 | 27452117 | |
| 430 | Ubiquitination | FAANSRAKTNADTDG CCCCCCCCCCCCCCC | 41.00 | - | |
| 435 | Phosphorylation | RAKTNADTDGMVKIL CCCCCCCCCCCCHHC | 31.85 | - | |
| 440 | Ubiquitination | ADTDGMVKILGQKST CCCCCCCHHCCCCCC | 24.26 | 21890473 | |
| 440 | 2-Hydroxyisobutyrylation | ADTDGMVKILGQKST CCCCCCCHHCCCCCC | 24.26 | - | |
| 440 | Ubiquitination | ADTDGMVKILGQKST CCCCCCCHHCCCCCC | 24.26 | 21890473 | |
| 445 | 2-Hydroxyisobutyrylation | MVKILGQKSTDRVLG CCHHCCCCCCCCEEE | 54.23 | - | |
| 445 | Acetylation | MVKILGQKSTDRVLG CCHHCCCCCCCCEEE | 54.23 | 25953088 | |
| 445 | Ubiquitination | MVKILGQKSTDRVLG CCHHCCCCCCCCEEE | 54.23 | - | |
| 477 | Glutathionylation | ALEYGASCEDIARVC HHHHCCCHHHHHHHH | 5.59 | 22555962 | |
| 484 | Glutathionylation | CEDIARVCHAHPTLS HHHHHHHHHHCCCHH | 1.63 | 22555962 | |
| 502 | Phosphorylation | REANLAASFGKSINF HHHHHHHHHCCCCCC | 28.99 | 25159151 | |
| 505 | Acetylation | NLAASFGKSINF--- HHHHHHCCCCCC--- | 46.26 | - | |
| 505 | Methylation | NLAASFGKSINF--- HHHHHHCCCCCC--- | 46.26 | - | |
| 505 | Succinylation | NLAASFGKSINF--- HHHHHHCCCCCC--- | 46.26 | - | |
| 505 | Succinylation | NLAASFGKSINF--- HHHHHHCCCCCC--- | 46.26 | - | |
| 505 | Ubiquitination | NLAASFGKSINF--- HHHHHHCCCCCC--- | 46.26 | - | |
| 506 | Phosphorylation | LAASFGKSINF---- HHHHHCCCCCC---- | 24.12 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 135 | T | Phosphorylation | Kinase | RIPK3 | Q9Y572 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DLDH_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DLDH_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 246900 | Dihydrolipoamide dehydrogenase deficiency (DLDD) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-143; LYS-267; LYS-320;LYS-410; LYS-417 AND LYS-420, AND MASS SPECTROMETRY. | |